vimarsana.com

Page 2 - தேசிய நிறுவனம் ஆஃப் ஒவ்வாமை மற்றும் தொற்று நோய்கள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Sen Tom Cotton slams Fauci for covering his track on his links to Chinese virology laboratory

Sen. Tom Cotton (R-AR) criticized top American infectious disease expert Dr. Anthony Fauci during a television appearance. The lawmaker accused Fauci of "playing word games" and [.]

Rand Paul: NIH Funded the Wuhan Lab, Fauci s Parsing Ignores that Money Is Fungible

US begins study of allergic reactions from mRNA coronavirus vaccines, proving covid vaccine long-term safety studies have never been conducted

The U.S. will start a study focusing on the allergic reactions triggered by mRNA Wuhan coronavirus (COVID-19) vaccines. The trial, conducted by the National Institute of Allergy and Infectious [.]

FORUM 1: Why don t some Americans trust public health officials on COVID vaccinations? Fauci, Walensky haven t been candid with them

ON MARCH 29, Dr. Rochelle Walensky, the director of the Centers for Disease Control, shared “the recurring feeling I have of impending doom.” She later gave MSNBC viewers some good news: “Our data from the CDC today suggests, you know, that vaccinated people do not carry the virus, don’t get sick.” Three days later, a CDC spokesman took it back: “Dr. Walensky spoke broadly during this interview. It’s possible that some people who are fully vaccinated could get COVID-19. The evidence isn’t clear whether they can spread the virus to others. We are continuing to evaluate the evidence.”

CoVIg-19 Plasma Alliance Announces Topline Results from NIH-Sponsored Clinical Trial of Investigational COVID-19 Hyperimmune Globulin Medicine

CoVIg-19 Plasma Alliance Saturday, April 3, 2021 2:00PM IST (8:30AM GMT)   Osaka, Japan & King of Prussia, Pa., United States:    Phase 3 Inpatient Treatment With Anti-Coronavirus Immunoglobulin (ITAC) Clinical Trial Sponsored and Funded by the National Institute of Allergy and Infectious Diseases (NIAID), Part of the National Institutes of Health (NIH), Did Not Meet Its Endpoints to Show Efficacy in Adults Hospitalized With COVID-19 The CoVIg-19 Plasma Alliance today announced that the Phase 3 Inpatient Treatment with Anti-Coronavirus Immunoglobulin (ITAC) clinical trial sponsored and funded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), did not meet its endpoints. No serious safety signals were raised in the trial.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.